Observational Study
Copyright ©The Author(s) 2025.
World J Methodol. Mar 20, 2025; 15(1): 98482
Published online Mar 20, 2025. doi: 10.5662/wjm.v15.i1.98482
Table 1 Characteristics of study populations, n (%)/mean ± SD
Parameter
NMOSD group
MOGAD group
Control group
Average age (years)39.636.936.9
SexMale1 (12.5)6 (35)3 (30)
Female7 (87.5)11 (65)7 (70)
LateralityUnilateral8 (100)9 (53)NA
Bilateral0 (0)8 (47)
Average visual acuity of affected eye at presentation (LogMAR)2.42 ± 0.561.13 ± 0.86NA
Average final visual acuity of affected eye (LogMAR)0.77 ± 0.950.15 ± 0.25NA
Table 2 Averages of collected data, mean ± SD
Variable measuredNMOSD group
MOGAD group
Control group
Affected eyes
Unaffected eyes
Affected eyes
Unaffected eyes
Healthy eyes
Average macular vascular density (mm/mm2)16.6 ± 2.418.6 ± 3.316.0 ± 3.818.6 ± 1.431.8 ± 5.8
Average ganglion cell + inner plexiform layer thickness (micrometers)52.4 ± 10.068.5 ± 7.953.1 ± 11.366.5 ± 5.469.67 ± 7.6
Table 3 Comparison of neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody disorder group with controls
Variable comparedP values
NMOSD affected eyes compared to controls
NMOSD unaffected eyes compared to controls
NMOSD affected eyes compared to NMO unaffected eyes
MOGAD affected eyes compared to controls
MOGAD unaffected eyes compared to controls
MOGAD affected eyes compared to MOGAD unaffected eyes
NMO affected eyes compared to MOGAD affected eyes
NMO unaffected eyes compared to MOGAD unaffected eyes
Macular vascular density0.00020.00480.12280.00010.00120.32070.78140.6321
Average ganglion cell + inner plexiform layer thickness0.00160.53980.00910.00030.00090.14720.88760.5622